Machine Learning

As Autolus heads to key investor conferences, its strong AUCATZYL® sales and deep pipeline face scrutiny against mounting losses and a curious PR misstep.

SLC Digital and Tracer Labs partner to combat rampant account takeover fraud, combining hardware-rooted security with a privacy-first digital identity.

Riding a wave of 41% Q4 revenue growth and nearing profitability, the diagnostics firm will showcase its lung cancer solutions at two major conferences.

Nokia and AWS launch a thinking 5G network with du and Orange. Their agentic AI promises to unlock the true business potential of network slicing.

A new screen protector promises glasses-free 3D on your iPhone. Can MOPIC succeed where tech giants have repeatedly failed?

Avacta's pre|CISION therapy shows faster, more potent, and more selective tumor targeting than Enhertu in an AI-driven study, paving the way for 2026 trials.

With key conferences ahead, Supernus Pharmaceuticals must prove its strategy can deliver growth in the competitive central nervous system drug landscape.

The fusion energy pioneer plans to go public via a SPAC merger, seeking capital to prove its unique technology and win the race for limitless clean power.

Beam Therapeutics is set to announce its 2025 financial results and a new liver-targeted therapy, a key moment for its base editing platform and investors.

With promising data in cancer and eczema, all eyes are on Corvus Pharmaceuticals as it presents its lead drug at a major healthcare conference this week.

A former hedge fund manager's stark video presentation warns that AI will permanently alter work and wealth. Are American workers prepared for what's next?

Following strong earnings and a major SAP settlement, Teradata will detail its AI-driven future and financial outlook at two key investor conferences.

With a new CEO and a key investor conference ahead, Metagenomi bets on its unique metagenomics platform and a hemophilia drug to navigate a tough market.

Top veterinary group endorses Visbiome Vet for chronic gut issues, setting a new evidence-based standard in a crowded, unregulated pet supplement market.

A new $3M federal investment aims to help over 400 Prairie manufacturers navigate global trade volatility through advanced training and operational support.

A new partnership promises streamlined care for patients but also signals a major shift in the region's healthcare landscape as an independent practice joins a giant.

A top legal award for David Wittmann reveals his crucial role in guiding Massachusetts' tech startups and his deep commitment to community service.

A new wellness program by celebrity psychiatrist Dr. Daniel Amen is launching in churches, blending neuroscience with scripture to fight a national health crisis.

The deal merges Optimal's performance media with OneMagnify's AI platform, accelerating a private equity-backed push to dominate B2B marketing.

Arctic Wolf's strategic acquisition of exposure assessment visionary Sevco Security signals a major industry pivot from reactive defense to proactive risk reduction.